Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-05-088440
Filing Date
2005-04-28
Accepted
2005-04-28 15:30:35
Documents
6
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 CYTOGEN CORPORATION--AMENDMENT #1 TO FORM 10-K d10ka.htm 10-K/A 205684
2 CERTIFICATION OF CEO dex311.htm EX-31.1 7433
3 CERTIFICATION OF CFO dex312.htm EX-31.2 7455
4 CERTIFICATION OF CEO dex321.htm EX-32.1 4233
5 CERTIFICATION OF CFO dex322.htm EX-32.2 4274
7 GRAPHIC g23514img001.jpg GRAPHIC 47782
  Complete submission text file 0001193125-05-088440.txt   296455
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

EIN.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-14879 | Film No.: 05780436
SIC: 2834 Pharmaceutical Preparations